|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNDER CONSTRUCTION | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Tuesday, October 31, 2006
Cladribine used to treat some cancers and possibly MS... scientists improve drug synthesis
A team of Brigham Young University researchers has come up with a more efficient way to synthesize the drug cladribine, the treatment of choice for certain "hairy cell" leukemias and a drug that is about to be tested as a possible treatment for multiple sclerosis. The finding was published this fall in the Journal of Organic Chemistry.... Besides treating some cancers, cladribine has been tried in various ways, says Robins — including recently gaining "fast-track" approval by the Food and Drug Administration for Serono to test its new oral cladribine treatment for MS. "It would be very exciting if they have found ways to treat MS patients, because it's such a debilitating condition," Robins says. MS affects about 2 million people worldwide.MORE |